EGFR806 CAR T Cell Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR806 CAR T Cell Immunotherapy, covering 2025-11-20 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults [Phase 1]